Aberrant sialylation and fucosylation of intracellular proteins in cervical tissue are critical markers of cervical carcinogenesis

Kim,Hyoung Jin; Kim,Seung Cheol; Ju,Woong; Kim,Yun Hwan; Yin,Sun Young; Kim,Hong-Jin

doi:10.3892/or.2013.2938

Aberrant sialylation and fucosylation of intracellular proteins in cervical tissue are critical markers of cervical carcinogenesis

Authors:
- Hyoung Jin Kim
- Seung Cheol Kim
- Woong Ju
- Yun Hwan Kim
- Sun Young Yin
- Hong-Jin Kim
View Affiliations

Affiliations: Laboratory of Virology, College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea, Department of Obstetrics and Gynecology, Ewha Womans University College of Medicine, Seoul, Republic of Korea
Published online on: December 20, 2013 https://doi.org/10.3892/or.2013.2938
Pages: 1417-1422

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Numerous studies have suggested that increased sialylation and fucosylation levels are signs of cancer progression. The majority of studies have focused on cell surface and bloodstream glycosylation changes associated with cancer progression, while little attention has been paid to changes in the glycosylation of cytosolic proteins. We compared the mannosylation, sialylation and fucosylation levels of cytosolic proteins obtained from human cervical tissues without neoplastic lesions vs. with cancer, using lectin blot and enzyme-linked lectin assay (ELLA) systems. There were no quantitative differences in mannosylation levels between the cytosolic proteins of normal and cancer tissues. However, we found markedly reduced sialylation (P<0.001) and fucosylation (P<0.01) in the proteins of cancer tissues. The ELLA system for detecting sialylation had extremely high sensitivity (91-100%) and specificity (82-100%) in distinguishing normal and cancer tissues. Thus, the changes in the glycosylation of cytosolic proteins during carcinogenesis of the cervix are quite different from previous observations concerning glycoconjugates in the bloodstream or on the cell surface. We suggest that changes in the glycosylation of intracellular proteins may be useful markers of the development of cervical cancer.

View Figures

View References

1	Walboomers JMM, Jacobs MV, Manos MM, et al: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI
2	Parkin DM and Bray F: Chapter 2: The burden of HPV-related cancers. Vaccine. 24(Suppl 3): S11–S25. 2006. View Article : Google Scholar
3	Steben M and Duarte-Franco E: Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol. 107:S2–S5. 2007. View Article : Google Scholar : PubMed/NCBI
4	Snijders PJ, Steenbergen RD, Heideman DA and Meijer CJ: HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol. 208:152–164. 2006. View Article : Google Scholar : PubMed/NCBI
5	Scheffner M, Romanczuk H, Munger K, Huibregtse JM, Mietz JA and Howley PM: Functions of human papillomavirus proteins. Curr Top Microbiol Immunol. 186:83–99. 1994.
6	Arbeit JM, Munger K, Howley PM and Hanahan D: Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J Virol. 68:4358–4368. 1994.PubMed/NCBI
7	Jin XW, Sikon A and Yen-Lieberman B: Cervical cancer screening: Less testing, smarter testing. Cleve Clin J Med. 78:737–747. 2011. View Article : Google Scholar : PubMed/NCBI
8	Wentzensen N and von Knebel Doeberitz M: Biomarkers in cervical cancer screening. Dis Markers. 23:315–330. 2007. View Article : Google Scholar
9	Maeda MY, Simoes M, Wakamatsu A, et al: Relevance of the rates of PCNA, Ki-67 and p53 expression according to the epithelial compartment in cervical lesions. Pathologica. 93:189–195. 2001.PubMed/NCBI
10	Sano T, Oyama T, Kashiwabara K, Fukuda T and Nakajima T: Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol. 153:1741–1748. 1998. View Article : Google Scholar : PubMed/NCBI
11	Shin JH, Grabowski B, Kasiviswanathan R, Bell SD and Kelman Z: Regulation of minichromosome maintenance helicase activity by Cdc6. J Biol Chem. 278:38059–38067. 2003. View Article : Google Scholar : PubMed/NCBI
12	Cook JG, Park CH, Burke TW, et al: Analysis of Cdc6 function in the assembly of mammalian prereplication complexes. Proc Natl Acad Sci USA. 99:1347–1352. 2002. View Article : Google Scholar : PubMed/NCBI
13	Duk JM, de Bruijn HW, Groenier KH, et al: Cancer of the uterine cervix: sensitivity and specificity of serum squamous cell carcinoma antigen determinations. Gynecol Oncol. 39:186–194. 1990. View Article : Google Scholar : PubMed/NCBI
14	von Knebel Doeberitz M, Reuschenbach M, Schmidt D and Bergeron C: Biomarkers for cervical cancer screening: the role of p16^INK4a to highlight transforming HPV infections. Expert Rev Proteomics. 9:149–163. 2012.PubMed/NCBI
15	Lorincz AT: Screening for cervical cancer: new alternatives and research. Salud Publica Mex. 45(Suppl 3): S376–S387. 2003. View Article : Google Scholar : PubMed/NCBI
16	An HJ and Lebrilla CB: A glycomics approach to the discovery of potential cancer biomarkers. Methods Mol Biol. 600:199–213. 2010. View Article : Google Scholar : PubMed/NCBI
17	Taylor AD, Hancock WS, Hincapie M, Taniguchi N and Hanash SM: Towards an integrated proteomic and glycomic approach to finding cancer biomarkers. Genome Med. 1:572009. View Article : Google Scholar : PubMed/NCBI
18	Zhu J, Wang Y, Yu Y, et al: Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues. Liver Int. Jul 1–2013. View Article : Google Scholar
19	Passaniti A and Hart GW: Cell surface sialylation and tumor metastasis. Metastatic potential of B16 melanoma variants correlates with their relative numbers of specific penultimate oligosaccharide structures. J Biol Chem. 263:7591–7603. 1988.
20	Mouiseddine M, Francois S, Semont A, et al: Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/severe combined immunodeficiency mouse model. Br J Radiol. 80(Spec No 1): S49–S55. 2007. View Article : Google Scholar
21	Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680–685. 1970. View Article : Google Scholar : PubMed/NCBI
22	Kim HJ, Lee SJ and Kim HJ: Antibody-based enzyme-linked lectin assay (ABELLA) for the sialylated recombinant human erythropoietin present in culture supernatant. J Pharm Biomed Anal. 48:716–721. 2008. View Article : Google Scholar : PubMed/NCBI
23	Wu AM, Lisowska E, Duk M and Yang ZG: Lectins as tools in glycoconjugate research. Glycoconjugate J. 26:899–913. 2009. View Article : Google Scholar : PubMed/NCBI
24	Thompson R, Creavin A, O’Connell M, O’Connor B and Clarke P: Optimization of the enzyme-linked lectin assay for enhanced glycoprotein and glycoconjugate analysis. Anal Biochem. 413:114–122. 2011. View Article : Google Scholar : PubMed/NCBI
25	Hossler P, Khattak SF and Li ZJ: Optimal and consistent protein glycosylation in mammalian cell culture. Glycobiology. 19:936–949. 2009. View Article : Google Scholar : PubMed/NCBI
26	Meany DL and Chan DW: Aberrant glycosylation associated with enzymes as cancer biomarkers. Clin Proteomics. 8:72011. View Article : Google Scholar : PubMed/NCBI
27	Magnoni C, Tenedini E, Ferrari F, et al: Transcriptional profiles in melanocytes from clinically unaffected skin distinguish the neoplastic growth pattern in patients with melanoma. Br J Dermatol. 156:62–71. 2007. View Article : Google Scholar : PubMed/NCBI
28	Funakoshi Y and Suzuki T: Glycobiology in the cytosol: the bitter side of a sweet world. Biochim Biophys Acta. 1790:81–94. 2009. View Article : Google Scholar : PubMed/NCBI
29	Harduin-Lepers A, Krzewinski-Recchi MA, Colomb F, Foulquier F, Groux-Degroote S and Delannoy P: Sialyltransferase functions in cancers. Front Biosci (Elite Ed). 4:499–515. 2012. View Article : Google Scholar
30	Miyagi T: Aberrant expression of sialidase and cancer progression. Proc Jpn Acad Ser B Phys Biol Sci. 84:407–418. 2008. View Article : Google Scholar : PubMed/NCBI
31	Lopez-Morales D, Reyes-Leyva J, Santos-Lopez G, Zenteno E and Vallejo-Ruiz V: Increased expression of sialic acid in cervical biopsies with squamous intraepithelial lesions. Diagn Pathol. 5:742010. View Article : Google Scholar : PubMed/NCBI
32	Krzeslak A, Gaj Z, Pomorski L and Lipinska A: Sialylation of intracellular proteins of thyroid lesions. Oncol Rep. 17:1237–1242. 2007.PubMed/NCBI
33	Shingleton HM, Patrick RL, Johnston WW and Smith RA: The current status of the Papanicolaou smear. CA Cancer J Clin. 45:305–320. 1995. View Article : Google Scholar : PubMed/NCBI
34	ACOG Committee on Practice Bulletins-Gynecology. ACOG Practice Bulletin no. 109: Cervical cytology screening. Obstet Gynecol. 114:1409–1420. 2009. View Article : Google Scholar : PubMed/NCBI